Patents by Inventor Thirumala-Devi Kanneganti

Thirumala-Devi Kanneganti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240018230
    Abstract: Methods for treating or mitigating COVID-19, sepsis or hemophagocytic lymphohistiocystosis or cytokine storm-associated syndromes; and treating or preventing inflammatory cell death associated with an inflammatory condition or infection such as SARS-CoV-2, or inducing inflammatory cell death in the context of cancer are provided, which includes the modulation of TNF and/or IFN-? activity.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 18, 2024
    Inventors: Thirumala-Devi KANNEGANTI, Rajendra KARKI
  • Publication number: 20080008652
    Abstract: The present invention relates to methods and compositions for modulating immune responses and adjuvant activity. In particular, the present invention provides methods and compositions for screening for compounds that modulate cryopyrin signaling.
    Type: Application
    Filed: January 10, 2007
    Publication date: January 10, 2008
    Applicant: The Regents of the University of Michigan
    Inventors: Gabriel Nunez, Thirumala-Devi Kanneganti